Qiagen N.V. (QGEN)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 42.24 |
| Open | 42.92 |
| Bid | 43.41 x 900 |
| Ask | 44.53 x 1800 |
| Day's range | 42.87 - 44.14 |
| 52-week range | 34.74 - 47.32 |
| Volume | |
| Avg. volume | 1,105,590 |
| Market cap | 9.748B |
| Beta (5Y monthly) | 0.40 |
| PE ratio (TTM) | 28.91 |
| EPS (TTM) | 1.52 |
| Earnings date | 31 Jul 2024 |
| Forward dividend & yield | 1.28 (2.94%) |
| Ex-dividend date | 30 Jan 2024 |
| 1y target est | 49.70 |
ZacksUltragenyx (RARE) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Ultragenyx (RARE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksQiagen (QGEN) Expected to Beat Earnings Estimates: Should You Buy?
Qiagen (QGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksIs QIAGEN (QGEN) a Good Investment Now? Key Factors to Note
QIAGEN's (QGEN) progress in test menu expansion, prospects in molecular diagnostics and strong solvency bode well.
© 2024 Yahoo. All rights reserved.